Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Minority Interest: 2015-2016

  • Outlook Therapeutics' Minority Interest was N/A to $17.4 million in Q1 2016 from the same period last year, while for Mar 2016 it was $17.4 million, marking a year-over-year change of. This contributed to the annual value of $27.3 million for FY2015, which is N/A change from last year.
  • Latest data reveals that Outlook Therapeutics reported Minority Interest of $17.4 million as of Q1 2016, which was down 36.33% from $27.3 million recorded in Q3 2015.
  • Over the past 5 years, Outlook Therapeutics' Minority Interest peaked at $27.3 million during Q3 2015, and registered a low of $17.4 million during Q1 2016.
  • Over the past 2 years, Outlook Therapeutics' median Minority Interest value was $22.4 million (recorded in 2015), while the average stood at $22.4 million.